Literature DB >> 8668144

TFIIH functions in regulating transcriptional elongation by RNA polymerase II in Xenopus oocytes.

K Y Yankulov1, M Pandes, S McCracken, D Bouchard, D L Bentley.   

Abstract

We investigated the role of TFIIH in transcription by RNA polymerase II (pol II) in vivo by microinjection of antibodies against this factor into Xenopus oocytes. Five different antibodies directed against four subunits of TFIIH were tested for effects on transcription of coinjected human immunodeficiency virus type 2 and c-myc templates. Each of these antibodies severely reduced the efficiency of elongation through human immunodeficiency virus type 2 and c-myc terminator elements. In contrast, an anti-TFIIB antibody did not inhibit elongation. Anti-TFIIH antibodies also had a much smaller inhibitory effect on total transcription than did anti-TFIIB or anti-pol II large subunit. Three inhibitors of TFIIH kinase activity, H-7, H-8, and dichlororibofuranosylbenzimidazole (DRB), inhibited elongation similarly to anti-TFIIH antibodies. These results strongly suggest a role for TFIIH in the stimulation of transcriptional elongation in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668144      PMCID: PMC231323          DOI: 10.1128/MCB.16.7.3291

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Recycling of the general transcription factors during RNA polymerase II transcription.

Authors:  L Zawel; K P Kumar; D Reinberg
Journal:  Genes Dev       Date:  1995-06-15       Impact factor: 11.361

Review 2.  Plasmid-based transgenic mouse model for studying in vivo mutations.

Authors:  M E Boerrigter; M E Dollé; H J Martus; J A Gossen; J Vijg
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

3.  Multifunctional RNA polymerase II initiation factor delta from rat liver. Relationship between carboxyl-terminal domain kinase, ATPase, and DNA helicase activities.

Authors:  H Serizawa; R C Conaway; J W Conaway
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

4.  A cap-binding protein complex mediating U snRNA export.

Authors:  E Izaurralde; J Lewis; C Gamberi; A Jarmolowski; C McGuigan; I W Mattaj
Journal:  Nature       Date:  1995-08-24       Impact factor: 49.962

5.  Three functional classes of transcriptional activation domain.

Authors:  J Blau; H Xiao; S McCracken; P O'Hare; J Greenblatt; D Bentley
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

6.  The transcriptional elongation inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase.

Authors:  K Yankulov; K Yamashita; R Roy; J M Egly; D L Bentley
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

7.  Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase.

Authors:  R P Fisher; P Jin; H M Chamberlin; D O Morgan
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

8.  Distinct properties of c-myc transcriptional elongation are revealed in Xenopus oocytes and mammalian cells and by template titration, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), and promoter mutagenesis.

Authors:  T Meulia; A Krumm; M Groudine
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

9.  The KIN28 gene is required both for RNA polymerase II mediated transcription and phosphorylation of the Rpb1p CTD.

Authors:  J G Valay; M Simon; M F Dubois; O Bensaude; C Facca; G Faye
Journal:  J Mol Biol       Date:  1995-06-09       Impact factor: 5.469

10.  MAT1 ('menage à trois') a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK.

Authors:  A Devault; A M Martinez; D Fesquet; J C Labbé; N Morin; J P Tassan; E A Nigg; J C Cavadore; M Dorée
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

View more
  21 in total

1.  hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation.

Authors:  M K Kim; V M Nikodem
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Transitions in the coupling of transcription and nucleotide excision repair within RNA polymerase II-transcribed genes of Saccharomyces cerevisiae.

Authors:  M Tijsterman; R A Verhage; P van de Putte; J G Tasseron-de Jong; J Brouwer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH.

Authors:  M Rossignol; I Kolb-Cheynel; J M Egly
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

4.  Regulation of CDK7 substrate specificity by MAT1 and TFIIH.

Authors:  K Y Yankulov; D L Bentley
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

5.  RNA polymerase II carboxy-terminal domain phosphorylation is required for cotranscriptional pre-mRNA splicing and 3'-end formation.

Authors:  Gregory Bird; Diego A R Zorio; David L Bentley
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

6.  MCM proteins are associated with RNA polymerase II holoenzyme.

Authors:  K Yankulov; I Todorov; P Romanowski; D Licatalosi; K Cilli; S McCracken; R Laskey; D L Bentley
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

7.  The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.

Authors:  K Fujinaga; T P Cujec; J Peng; J Garriga; D H Price; X Graña; B M Peterlin
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.

Authors:  T P Cujec; H Okamoto; K Fujinaga; J Meyer; H Chamberlin; D O Morgan; B M Peterlin
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

9.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.

Authors:  Y Zhu; T Pe'ery; J Peng; Y Ramanathan; N Marshall; T Marshall; B Amendt; M B Mathews; D H Price
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

10.  Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.

Authors:  L M Schang; A Rosenberg; P A Schaffer
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.